Orchid Island Capital Reports Q1 Net Loss, Significant Dilution from ATM Offerings, and Increased Leverage
Summary
Orchid Island Capital reported a net loss of $19.955 million for Q1 2026, a significant decline from the prior year's income, alongside substantial dilution from ongoing at-the-market offerings and an increase in leverage.
Key Events
-
Q1 2026 Net Loss
Reported a net loss of $19.955 million, a significant reversal from a $17.122 million net income in Q1 2025, resulting in a basic and diluted EPS of $(0.11).
-
Substantial Dilution from ATM Offerings
Issued 14.56 million shares in Q1 2026 for $107.8 million net proceeds, with an additional 4 million shares issued post-quarter for $27.8 million, totaling $135.6 million in new capital.
-
Increased Leverage
Economic leverage rose to 7.9:1 and adjusted leverage to 7.8:1 as of March 31, 2026, up from 7.4:1 at the end of 2025.
-
Dividend Cut Confirmed
The previously announced dividend cut to $0.10 per share (declared April 15, 2026) is contextualized within the full quarterly results.
Analysis
The company's first-quarter results show a notable deterioration in financial performance, with a net loss of $19.955 million compared to a net income of $17.122 million in Q1 2025. This financial downturn is compounded by aggressive capital raising through at-the-market (ATM) offerings, which resulted in $107.8 million in net proceeds during Q1 2026 and an additional $27.8 million post-quarter, leading to significant shareholder dilution. The company's economic and adjusted leverage ratios also increased, indicating a higher risk profile. While the dividend cut was previously announced, this filing provides the full financial context of the company's challenges. Investors should monitor the impact of ongoing dilution on per-share metrics and the company's ability to return to profitability in a volatile interest rate environment.
At the time of this filing, ORC was trading at $7.05 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $6.62 to $8.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.